MiR-29a promotes cell proliferation and EMT in breast cancer by targeting ten eleven translocation 1

被引:73
|
作者
Pei, Yao-fei [1 ]
Lei, Yao [2 ]
Liu, Xi-qiang [1 ]
机构
[1] Zhejiang Prov Peoples Hosp, Dept Hepatobiliary Pancreat Surg, Hangzhou 310014, Zhejiang, Peoples R China
[2] Hunan Prov Peoples Hosp, Dept Intervent Therapy & Vasc Surg, Changsha 410005, Hunan, Peoples R China
关键词
Breast cancer; Cell proliferation; EMT; MiR-29a; TET1; TUMOR-SUPPRESSOR; EXPRESSION; 5-HYDROXYMETHYLCYTOSINE; MICRORNA-148B; REGULATOR; CARCINOMA; MIRNAS;
D O I
10.1016/j.bbadis.2016.08.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Increasing evidence has shown that microRNAs played an important role in regulating carcinogenesis. However, the role of miR-29a in breast cancer is still unclear. Herein, we showed that miR-29a was significantly up-regulated in breast cancer as compared with non-tumor tissues. Moreover, the up-regulation of miR-29a was significantly correlated with tumor metastasis and shorter overall survival in breast cancer patients. Knockdown of miR-29a in breast cancer cell lines inhibited cell proliferation and migration. Furthermore, data from bioinformatic analysis validated by dual-luciferase reporter gene assay showed that ten eleven translocation 1 (TET1) was a direct target of miR-29a, and over-expression of TET1 inhibited cell proliferation and migration which could be induced by the up-regulation of miR-29a. TET1 silencing promoted cell growth and migration in breast cancer. MiR-29a over-expression had the same effect. MiR-29a targets TET1, down regulates its expression and thus promotes EMT in breast cancer. Altogether, we demonstrate that miR-29a acts as a tumor activator by targeting TETI and induces cell proliferation and EMT in breast cancer. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:2177 / 2185
页数:9
相关论文
共 50 条
  • [41] Tamoxifen differentially regulates miR-29b-1 and miR-29a expression depending on endocrine-sensitivity in breast cancer cells
    Muluhngwi, Penn
    Krishna, Abirami
    Vittitow, Stephany L.
    Napier, Joshua T.
    Richardson, Kirsten M.
    Ellis, Mackenzie
    Mott, Justin L.
    Klinge, Carolyn M.
    CANCER LETTERS, 2017, 388 : 230 - 238
  • [42] MiR-29a is down-regulated and inhibits cell proliferation in osteosarcoma: a meta analysis
    Luo, Jin-Zhu
    Zhu, Jing
    Zhang, Ling
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (05): : 5122 - 5129
  • [43] Inhibiting of TACC3 Promotes Cell Proliferation, Cell Invasion and the EMT Pathway in Breast Cancer
    Huo, Qin
    Chen, Siqi
    Li, Zhenwei
    Wang, Juan
    Li, Jiaying
    Xie, Ni
    FRONTIERS IN GENETICS, 2021, 12
  • [44] miR-639 promotes the proliferation and invasion of breast cancer cell in vitro
    Li, Lin
    Qiu, Xin-guang
    Lv, Peng-wei
    Wang, Fang
    CANCER CELL INTERNATIONAL, 2014, 14
  • [45] MiR-29a promotes osteogenic differentiation of mesenchymal stem cells via targeting HDAC4
    Tan, K.
    Peng, Y. -T.
    Guo, P.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (11) : 3318 - 3326
  • [46] miR-639 promotes the proliferation and invasion of breast cancer cell in vitro
    Lin Li
    Xin-guang Qiu
    Peng-wei Lv
    Fang Wang
    Cancer Cell International, 14
  • [47] miR-29a activates Hes1 by targeting Nfia in esophageal carcinoma cell line TE-1
    Liu, Chang
    Duan, Ping
    Li, Bo
    Huang, Chuntian
    Jing, Ying
    Yan, Wenhai
    ONCOLOGY LETTERS, 2015, 9 (01) : 96 - 102
  • [48] Targeting of TLE3 by miR-3677 in human breast cancer promotes cell proliferation, migration and invasion
    Peng, Li-Na
    Deng, Xing-Yan
    Gan, Xiao-Xiong
    Zhang, Jin-Hui
    Ren, Guang-Hui
    Shen, Fei
    Feng, Jian-Hua
    Cai, Wen-Song
    Xu, Bo
    ONCOLOGY LETTERS, 2020, 19 (02) : 1409 - 1417
  • [49] miR-216a promotes breast cancer cell apoptosis by targeting PKCα
    Cui, Ying
    Wang, Jinghao
    Liu, Shanshan
    Qu, Di
    Jin, Hong
    Zhu, Lin
    Yang, Jiani
    Zhang, Jingchun
    Li, Qingwei
    Zhang, Yanqiao
    Yao, Yuanfei
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 (04) : 397 - 404
  • [50] MiR-26b-5p inhibits cell proliferation and EMT by targeting MYCBP in triple-negative breast cancer
    Ma, Sugang
    Wei, Hui
    Wang, Chunyan
    Han, Jixia
    Chen, Xiumin
    Li, Yang
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2021, 26 (01)